ADUS vs ENSG vs INNV Stock Comparison

Addus HomeCare, Ensign and InnovAge Holding Prices as of Oct 28, 2026 Peers: Industry group
ADUS Addus HomeCare Corp
$122.18 +9.2% 1M +1.4% 1Y
Market cap
$2.28B
P/E
21.2x
Revenue (TTM)
$1.48B
Div. yield
–
Home Health and Senior Care Healthcare
5 wins
ENSG Ensign Group, Inc
$184.11 +4.4% 1M -0.8% 1Y
Market cap
$10.74B
P/E
26.7x
Revenue (TTM)
$5.67B
Div. yield
0.15%
Home Health and Senior Care Healthcare
4 wins
INNV InnovAge Holding Corp.
$9.10 +2.4% 1M +79.1% 1Y
Market cap
$1.24B
P/E
–
Revenue (TTM)
$989.71M
Div. yield
–
Home Health and Senior Care Healthcare
2 wins

Head to Head

11 decided of 12

Addus HomeCare leads on 5 of the 12 questions below (Addus HomeCare 5, Ensign 4, InnovAge Holding 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionADUSENSGINNVLeader
Larger companyMarket capitalisation $2.28B $10.74B $1.24B ENSG
Cheaper on earningsLower P/E, profitable companies only 21.2x 26.7x -486.7x ADUS
Cheaper on forward earningsLower price / next fiscal year consensus EPS 17.0x 22.2x 20.2x ADUS
Faster revenue growthRevenue growth, trailing twelve months +15.9% +17.5% +15.9% ENSG
More profitableNet margin, trailing twelve months 7.1% 7.0% -0.3% ADUS
Better return on capitalReturn on invested capital 9.2% 14.3% 0.0% ENSG
Less leveragedLower net debt / EBITDA -0.2x -0.3x -3.8x INNV
Higher dividend yieldTrailing dividend yield — 0.15% — –
Better 1-year returnPrice return, last 12 months +1.4% -0.8% +79.1% INNV
Better 5-year returnAnnualised price return, 5 years +5.5%/yr +18.8%/yr +6.6%/yr ENSG
Less volatileAnnualised volatility, 1 year 29.2% 29.3% 72.7% ADUS
Higher overall scoreMean of the five percentile scores vs peers 69/100 64/100 66/100 ADUS

Percentile Scorecard

ADUSENSGINNV

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisADUSENSGINNV
Valuation 87 #13 of 92 69 #29 of 92 65 #33 of 92
Growth 61 #35 of 87 63 #33 of 87 87 #12 of 87
Profitability 73 #24 of 86 75 #22 of 86 49 #44 of 86
Financial Health 87 #14 of 97 72 #28 of 97 64 #36 of 97
Shareholder Returns 41 #33 of 55 43 #32 of 55 –
Overall 69 64 66
  • ADUS ranked among 102 companies in Healthcare Providers
  • ENSG ranked among 102 companies in Healthcare Providers
  • INNV ranked among 102 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodADUSENSGINNVSPY
1 month +9.2%+4.4%+2.4% +0.9%
3 months +2.6%+1.2%-20.7% +5.9%
6 months +26.0%-1.2%+12.8% +8.5%
Year to date +13.8%+5.7%+75.3% +13.3%
1 year +1.4%-0.8%+79.1% +12.4%
3 years +49.1%+89.2%+63.7% +88.1%
3 years, per year +14.3%+23.7%+17.9% +23.5%
5 years +30.7%+136.0%+37.5% +68.2%
5 years, per year +5.5%+18.8%+6.6% +11.0%
10 years +389.5%+980.5%— +263.4%
10 years, per year +17.2%+26.9%— +13.8%

Risk

MeasureADUSENSGINNVSPY
Volatility, 1Y 29.2%29.3%72.7% 12.7%
Downside volatility, 1Y 30.9%24.9%65.7% 12.7%
Beta vs S&P 500, 1Y 0.18-0.060.55 1.00
Return / volatility, 1Y 0.05-0.031.09 0.98
Max drawdown, 5Y -34.9%-31.8%-71.0% -25.4%
From 52-week high -0.5%-14.7%-24.9% -0.9%
52-week high $122.75$215.83$12.11 $779.14
52-week low $88.49$147.13$3.99 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleADUSENSGINNV
P/E now vs peer median 21.2xmedian 25.6x 26.7xmedian 25.6x -486.7xmedian 25.6x
P/S now vs peer median 1.5xmedian 1.6x 1.9xmedian 1.6x 1.3xmedian 1.6x
EV/EBITDA now vs peer median 13.5xmedian 16.3x 16.7xmedian 16.3x 46.7xmedian 16.3x
P/FCF now vs peer median 14.7xmedian 21.3x 21.1xmedian 21.3x 24.6xmedian 21.3x
P/B now vs peer median 2.0xmedian 3.3x 4.2xmedian 3.3x 5.2xmedian 3.3x
PEG now vs peer median 1.07median 0.68 1.68median 0.68 -8.07median 0.68

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsADUSENSGINNV
Revenue $1.48B $5.67B $989.71M
Gross profit $477.75M $1.20B $677.61M
Operating income $148.23M $509.16M $2.62M
Net income $105.31M $399.32M -$1.83M
Free cash flow $154.77M $509.91M $50.41M
EPS (diluted) $5.70 $6.73 $-0.02
Cash & equivalents $99.57M $337.59M $97.89M
Total debt $61.60M $198.72M $48.06M
Shares (diluted) 18.47M 59.30M 135.70M
Enterprise value $1.90B $8.87B $752.51M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricADUSENSGINNV
P/E 21.2x 26.7x -486.7x
P/FCF 14.7x 21.1x 24.6x
P/Operating cash flow 14.0x 15.4x 19.1x
P/S 1.5x 1.9x 1.3x
P/B 2.0x 4.2x 5.2x
P/Tangible book 2.2x 4.2x 5.3x
EV/EBITDA 13.5x 16.7x 46.7x
EV/EBIT 15.1x 20.7x 437.2x
EV/Revenue 1.5x 1.9x 1.2x
EV/FCF 14.5x 20.7x 22.7x
EV/Operating cash flow 13.8x 15.2x 17.7x
PEG (3Y EPS CAGR) 1.07 1.68 -8.07

Growth

14 metrics
MetricADUSENSGINNV
Revenue growth (1Y) 15.9% 17.5% 15.9%
Revenue CAGR (3Y) 13.9% 16.8% 12.9%
Gross profit growth (1Y) 15.1% 21.7% 15.9%
Gross profit CAGR (3Y) 14.9% 16.3% 12.5%
Operating income growth (1Y) 27.5% 26.6% 108.8%
Operating income CAGR (3Y) 23.6% 18.3% 27.1%
Net income growth (1Y) 26.9% 21.6% 94.9%
Net income CAGR (3Y) 25.1% 17.2% 65.2%
EPS growth (1Y) 26.0% 20.9% 91.6%
EPS CAGR (3Y) 19.9% 15.9% 60.4%
Operating cash flow growth (1Y) 61.7% 44.5% 96.9%
Operating cash flow CAGR (3Y) 16.4% 26.8% 47.3%
Free cash flow growth (1Y) 65.3% 76.1% 89.5%
Free cash flow CAGR (3Y) 17.9% 29.2% 162.9%

Profitability

14 metrics
MetricADUSENSGINNV
Gross margin 32.4% 21.2% 68.5%
EBITDA margin 11.3% 11.1% 2.5%
Operating margin 10.0% 9.0% 0.3%
Pretax margin 9.5% 9.4% 0.0%
Net margin 7.1% 7.0% -0.3%
FCF margin 10.5% 9.0% 5.1%
Operating cash flow margin 11.0% 12.3% 6.5%
Return on equity 9.3% 16.0% -0.3%
Return on assets 7.3% 6.8% -0.1%
Return on invested capital 9.2% 14.3% 0.0%
Return on capital employed 11.6% 10.4% 0.8%
Asset turnover 1.0x 1.0x 1.8x
Cash conversion (OCF / net income) 1.5x 1.7x -35.4x
Stock comp / revenue 1.2% 1.1% 0.7%

Financial Health

11 metrics
MetricADUSENSGINNV
Debt / assets 4.2% 3.3% 8.6%
Debt / equity 0.1x 0.1x 0.2x
Net debt / EBITDA -0.2x -0.3x -3.8x
Debt / FCF 0.4x 0.4x 1.0x
Liabilities / assets 21.2% 57.3% 57.2%
Equity / assets 78.8% 42.7% 42.8%
Interest coverage 14.9x 62.8x –
Current ratio 1.7x 1.2x 1.1x
Quick ratio 1.5x 1.1x 0.9x
Cash ratio 0.6x 0.4x 0.7x
Altman Z-score 6.39 3.62 3.88

Shareholder Returns

7 metrics
MetricADUSENSGINNV
Dividend yield – 0.1% –
Net buyback yield -0.1% 0.2% –
Shareholder yield -0.1% 0.3% –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusADUSENSGINNV
Forward P/E 17.0xFY2026 22.2xFY2026 20.2xFY2027
EPS, next fiscal year $7.20FY2026 $8.29FY2026 $0.45FY2027
EPS growth, next FY +15.6%FY2026 +26.2%FY2026 –
EPS growth, the year after +11.1% -1.8% +4.4%
Revenue, next fiscal year $1.57BFY2026 $5.76BFY2026 $1.00BFY2027
Revenue growth, next FY +10.8%FY2026 +13.9%FY2026 +1.5%FY2027
Revenue growth, the year after +6.1% +16.9% +11.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersADUSENSGINNV
Held by institutions 100.0% 89.8% 13.5%
Institutions holding 303 547 106
Change in shares held, QoQ +0.8% -1.2% +15.2%
Institutions buying 162 250 70
Institutions selling 94 213 24
Buyers to sellers 1.72 1.17 2.92

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ADUSENSGINNV
ADUS 1.00 0.35 0.06
ENSG 0.35 1.00 0.03
INNV 0.06 0.03 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ADUS, ENSG and INNV?

Ensign (ENSG) is the largest by market capitalisation: Addus HomeCare (ADUS) $2.28B, Ensign (ENSG) $10.74B, InnovAge Holding (INNV) $1.24B.

Which stock is cheaper, ADUS, ENSG and INNV?

Addus HomeCare (ADUS) trades on the lowest price-to-earnings ratio (Addus HomeCare (ADUS) 21.2x, Ensign (ENSG) 26.7x, InnovAge Holding (INNV) -486.7x). On next year's consensus earnings, Addus HomeCare (ADUS) is cheapest (Addus HomeCare (ADUS) 17.0x, Ensign (ENSG) 22.2x, InnovAge Holding (INNV) 20.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Ensign (ENSG) grew revenue fastest over the trailing twelve months: Addus HomeCare (ADUS) +15.9%, Ensign (ENSG) +17.5%, InnovAge Holding (INNV) +15.9%.

Which company is more profitable?

Addus HomeCare (ADUS) has the highest net margin (Addus HomeCare (ADUS) 7.1%, Ensign (ENSG) 7.0%, InnovAge Holding (INNV) -0.3%). On return on invested capital, Ensign (ENSG) leads (Addus HomeCare (ADUS) 9.2%, Ensign (ENSG) 14.3%, InnovAge Holding (INNV) 0.0%).

Which stock has performed better?

Over the past year InnovAge Holding (INNV) returned the most: Addus HomeCare (ADUS) +1.4%, Ensign (ENSG) -0.8%, InnovAge Holding (INNV) +79.1%. Over five years, Ensign (ENSG) compounded fastest (Addus HomeCare (ADUS) +5.5%/yr, Ensign (ENSG) +18.8%/yr, InnovAge Holding (INNV) +6.6%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Ensign (ENSG) 0.15%. Addus HomeCare (ADUS) and InnovAge Holding (INNV) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Addus HomeCare (ADUS) has been the steadiest (Addus HomeCare (ADUS) 29.2%, Ensign (ENSG) 29.3%, InnovAge Holding (INNV) 72.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ADUS, ENSG and INNV?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Addus HomeCare (ADUS) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.